N/A
Completed N=82
Propofol and Sevoflurane for Catheter-Related Bladder Discomfort
Catheter Site Discomfort · Complications · Anesthesia · Bladder Cancer
Source: ClinicalTrials.gov NCT02252445 ↗
Enrolled (actual)
82
Serious AEs
0.0%
Results posted
Sep 2016
Primary outcomePrimary: Catheter-related Bladder Discomfort — 35; 24 participants
Summary
The investigators want to evaluate the efficacy of the propofol and sevoflurane for the prevention of catheter-related bladder discomfort.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Catheter-related Bladder Discomfort |
38; 27 | — |
| SECONDARY Catheter-related Bladder Discomfort |
38; 27 | — |
| SECONDARY Hemodynamic Parameters |
90; 88 | — |
| SECONDARY Nausea |
2; 3 | — |
| SECONDARY Vomiting |
2; 1 | — |
| SECONDARY Dry Mouth |
2; 2 | — |
| SECONDARY Flushing |
0; 0 | — |
| SECONDARY Blurred Vision |
0; 0 | — |
| SECONDARY Dizziness |
0; 0 | — |
| SECONDARY Analgesics |
22; 13 | — |
Eligibility Criteria
Inclusion Criteria
- Patients scheduled for transurethral bladder excision under general anesthesia
- ASA I-III
Exclusion Criteria
- Foley catheter less than 18 Fr.
- Patients with obstruction of urinary tract
- Patients with neurogenic bladder
- Patients with severe obesity
- Patients with neurologic disorder
- Patients with chronic pain
- Patients with allergic history to propofol or sevoflurane
Data sourced from ClinicalTrials.gov (NCT02252445). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.